| TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy CW Eskelund, C Dahl, JW Hansen, M Westman, A Kolstad, LB Pedersen, ... Blood, The Journal of the American Society of Hematology 130 (17), 1903-1910, 2017 | 375 | 2017 |
| 15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (MCL 2): prolonged remissions without survival plateau CW Eskelund, A Kolstad, M Jerkeman, R Räty, A Laurell, S Eloranta, ... British journal of haematology 175 (3), 410-418, 2016 | 221 | 2016 |
| Molecular monitoring after autologous stem cell transplantation and preemptive rituximab treatment of molecular relapse; results from the nordic mantle cell lymphoma studies … A Kolstad, LB Pedersen, CW Eskelund, S Husby, K Grønbæk, ... Biology of Blood and Marrow Transplantation 23 (3), 428-435, 2017 | 73 | 2017 |
| Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality JW Hansen, DA Pedersen, LA Larsen, S Husby, SB Clemmensen, ... Blood, The Journal of the American Society of Hematology 135 (4), 261-268, 2020 | 56 | 2020 |
| Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study S Husby, F Favero, C Nielsen, BS Sørensen, J Bæch, K Grell, JW Hansen, ... Leukemia 34 (12), 3256-3268, 2020 | 54 | 2020 |
| miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator S Husby, U Ralfkiaer, C Garde, R Zandi, S Ek, A Kolstad, M Jerkeman, ... Blood, The Journal of the American Society of Hematology 125 (17), 2669-2677, 2015 | 54 | 2015 |
| Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL CW Eskelund, S Husby, F Favero, TW Klausen, FG Rodriguez-Gonzalez, ... Blood, The Journal of the American Society of Hematology 135 (22), 2000-2004, 2020 | 29 | 2020 |
| Mature lymphoid malignancies: origin, stem cells, and chronicity S Husby, K Grønbæk Blood advances 1 (25), 2444-2455, 2017 | 27 | 2017 |
| Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials M Dahl, S Husby, CW Eskelund, S Besenbacher, S Fjelstrup, C Côme, ... Leukemia 36 (1), 177-188, 2022 | 18 | 2022 |
| MicroRNAs in mantle cell lymphoma S Husby, C Geisler, K Grønbæk Leukemia & lymphoma 54 (9), 1867-1875, 2013 | 14 | 2013 |
| Protein phosphatase, Mg2+/Mn2+‐dependent 1D (PPM1D) mutations in haematological cancer S Husby, E Hjermind Justesen, K Grønbæk British Journal of Haematology 192 (4), 697-705, 2021 | 9 | 2021 |
| Molecular monitoring and tailored strategy with pre-emptive rituximab treatment for molecular relapse; results from the nordic mantle cell lymphoma studies (MCL2 and MCL3) with … A Kolstad, LB Pedersen, CW Eskelund, S Husby, K Grønbæk, ... Blood 128 (22), 146, 2016 | 9 | 2016 |
| Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based … T Trab, J Baech, LH Jakobsen, S Husby, MT Severinsen, S Eloranta, ... The Lancet Haematology 10 (10), e838-e848, 2023 | 4 | 2023 |
| Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement … AS Gerdtsson, J de Matos Rodrigues, CW Eskelund, S Husby, K Grønbæk, ... Haematologica 108 (4), 1092, 2023 | 3 | 2023 |
| A Circular RNA molecule, circRAB11FIP1, is associated with TP53 mutations and is of potential prognostic and functional significance in mantle cell lymphoma: Data from the … M Dahl, S Husby, CW Eskelund, C Côme, S Ek, A Kolstad, R Räty, ... Blood 134, 1495, 2019 | 3 | 2019 |
| Practical use of natriuretic peptide measurement: questionnaire results from general practitioners and cardiologists S Husby, B Lind, JP Goetze Biomarkers in Medicine 6 (1), 13-18, 2012 | 3 | 2012 |
| Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL S Husby, C Bæch-Laursen, CW Eskelund, F Favero, JS Jespersen, ... Leukemia 36 (12), 2912-2916, 2022 | 2 | 2022 |
| Mutations known from B-cell lymphoid malignancies are not found in CD34+ stem cells from patients with lymphoma S Husby, F Favero, FG Rodriguez-Gonzalez, LA Sutton, EK Haastrup, ... Leukemia & Lymphoma 62 (11), 2808-2811, 2021 | 2 | 2021 |
| Clinical impact of clonal hematopoiesis after autologous stem cell transplantation for lymphoma: A National Population-Based Cohort Study S Husby, F Francesco, C Nielsen, B Sørensen, J Bæch, JW Hansen, ... Blood 132, 607, 2018 | 2 | 2018 |
| Cardiovascular diseases after high‐dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population‐based study J Baech, S Husby, T Trab, K Kragholm, P Brown, JS Gørløv, ... British Journal of Haematology 204 (3), 967-975, 2024 | 1 | 2024 |
